Dr. Ding is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1800 Orleans Street
Bloomberg 11N
Baltimore, MD 21287Phone+1 410-955-8751Fax+1 410-614-1802
Summary
- Dr. Yang-Yang Ding is a pediatric hematologist/oncologist in Baltimore, MD and is affiliated with Johns Hopkins University. She received her medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 5 years. She also speaks multiple languages, including Chinese (Mandarin) and Spanish. She is experienced in pediatric hematology / oncology (particularly pediatric leukemias), pediatric neuro-oncology, pediatric solid tumor oncology, and pediatric stem cell transplantation.
Education & Training
- Children's Hospital of PhiladelphiaResidency, Pediatrics, 2012 - 2015
- Perelman School of Medicine at the University of PennsylvaniaClass of 2012
- Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology
- Yale UniversityBS, Molecular, Cellular and Developmental Biology, Magna Cum Laude, Phi Beta Kappa
Certifications & Licensure
- MD State Medical License 2023 - 2026
- PA State Medical License 2012 - 2024
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 1 citationsA multiomic atlas identifies a treatment-resistant, bone marrow progenitor-like cell population in T cell acute lymphoblastic leukemia.Jason Xu, Changya Chen, Jonathan H Sussman, Satoshi Yoshimura, Tiffaney Vincent
Nature Cancer. 2024-11-25 - 2 citationsIdentification and targeting of treatment resistant progenitor populations in T-cell Acute Lymphoblastic Leukemia.Kai Tan, Jason Xu, Changya Chen, Tiffaney Vincent, Petri Pölönen
Research Square. 2023-10-30 - 40 citationsSingle-cell multiomics reveals increased plasticity, resistant populations, and stem-cell-like blasts in KMT2A-rearranged leukemia.Changya Chen, Wenbao Yu, Fatemeh Alikarami, Qi Qiu, Chia-Hui Chen
Blood. 2022-04-07
Journal Articles
- Optimal control nodes in disease-perturbed networks as targets for combination therapyHu, Yuxuan; Chen, Chia-hui; Ding, Yang-yang; Wen, Xiao; Wang, Bingbo; Gao, Lin; Tan, Kai, Nature Communications, 5/16/2019
Authored Content
- JAKing Up Targeted Therapy for Ph-like Acute Lymphoblastic LeukemiaFebruary 2019
Professional Memberships
- Member
- American Association for Cancer Research (AACR)Member
- Children's Oncology Group (COG)Member
- Member
Other Languages
- Chinese (Mandarin), Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: